Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
318,510
-
Share change
-
-2,335,369
-
Total reported value
-
$1,487,000
-
Price per share
-
$4.67
-
Number of holders
-
3
-
Value change
-
-$2,999,458
-
Number of buys
-
1
-
Number of sells
-
19
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q1 2017
As of 31 Mar 2017,
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) was held by
3 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
318,510 shares.
The largest 3 holders included
Opaleye Management Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., and FNY Managed Accounts LLC.
This page lists
3
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.